Literature DB >> 20962556

[Pathology of endoscopic submucosal dissection; how do we interpret?].

Kyoung Mee Kim1, Cheol Keun Park.   

Abstract

It is widely accepted that endoscopic submucosal dissection (ESD) is an important treatment option for cases of early gastric carcinoma where the probability of lymph node metastasis is very low. The resected ESD specimens are carefully examined by serial sections at 2 mm intervals, and if pathology reveals submucosal invasion more than 500 μm and/or lymphovascular invasion, or if the resection margin is involved by the tumor, surgery is recommended. In this point of view, thorough pathologic examination and reporting the accurate pathologic diagnosis of ESD specimen is very important. The diagnostic approach and pitfalls in the diagnosis of ESD specimen are reviewed.

Entities:  

Mesh:

Year:  2010        PMID: 20962556     DOI: 10.4166/kjg.2010.56.4.214

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  3 in total

1.  Clinical outcomes of endoscopic submucosal dissection for undifferentiated or submucosal invasive early gastric cancer.

Authors:  Pyung Gohn Goh; Hyun Yong Jeong; Min Jung Kim; Hyuk Soo Eun; Hye Jin Kim; Eui Sik Kim; Yun Jeung Kim; Soo Youn Lee; Hee Seok Moon; Eaum Seok Lee; Seok Hyun Kim; Jae Kyu Sung; Byung Seok Lee
Journal:  Clin Endosc       Date:  2011-12-31

2.  Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion.

Authors:  Sun-Mi Lee; Sun Yang; Mee Joo; Kyoung-Mee Kim; Cheol Keun Park; Soomin Ahn; Byung-Hoon Min; Jun Haeng Lee; Seonwoo Kim; Jong Chul Rhee; Jae J Kim; Gregory Y Lauwers
Journal:  Diagn Pathol       Date:  2014-02-20       Impact factor: 2.644

3.  A Novel Fixation Method for Variable-Sized Endoscopic Submucosal Dissection Specimens: An In Vitro Animal Experiment.

Authors:  Seung Han Kim; Hyuk Soon Choi; Hoon Jai Chun; In Kyung Yoo; Jae Min Lee; Eun Sun Kim; Bora Keum; Yeon Seok Seo; Yoon Tae Jeen; Hong Sik Lee; Soon Ho Um; Chang Duck Kim
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.